Related Experiment Videos
Chronic myeloid leukemia: why does it evolve from chronic phase to blast transformation?
Tariq I Mughal1, John M Goldman
1Division of Hematology and Oncology, University of Massachusetts Medical School, Worcester, MA 01655, USA. tmughal@freenet.co.uk
Frontiers in Bioscience : a Journal and Virtual Library
|September 9, 2005
Summary
Chronic myeloid leukemia (CML) progresses from a chronic phase to an advanced blast phase. The molecular mechanisms driving this evolution from chronic myeloid leukemia to blast transformation remain largely unknown.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by the Philadelphia chromosome.
- CML typically presents in a chronic phase and can progress to accelerated or blast phases.
Purpose of the Study:
- To review the known mechanisms underlying CML progression.
- To elucidate the molecular basis of CML evolution from chronic to blast phase.
Main Methods:
- Literature review of studies on CML pathogenesis and progression.
- Analysis of genetic events and molecular alterations in CML.
Main Results:
- CML progression involves evolution within the BCR-ABL positive clone.
- Additional genetic events are hypothesized to drive disease transformation.
- The precise molecular basis for CML progression remains to be fully elucidated.
Conclusions:
- Understanding CML progression is crucial for developing targeted therapies.
- Further research into the molecular mechanisms of CML blast transformation is warranted.